Angiotensin Converting Enzyme Inhibitors.

Intro -- ANGIOTENSIN CONVERTING ENZYME INHIBITORS -- Contents -- Preface -- Angiotensin Converting Enzyme Inhibitors -- Abstract -- Introduction - The Components of the Renin Angiotensin Aldosterone System (RAAS) -- Structure and Structure Activity Relationships of the ACEIs -- Clinical Indications and Uses of the ACEIs -- Adverse Effects of the ACE Inhibitors with Special Reference to Worsening Renal Failure in CKD Patients -- Conclusion/Post-Script -- References -- Adverse Effects of Angiotensin-Converting Enzyme Inhibitor: A Review of the Literature -- Abstract -- Introduction -- ACEI-Associated Cough -- Hypersensitivity Reaction During Hemodialysis -- ACEI-Associated Anemia -- ACEI-Induced Lung Disease -- References -- Plant-Derived Substances as ACE Inhibitors - Biosynthesis-Activity Relationship of Flavonoids, Terpenes and Sterols on Angiotensin-Converting Enzyme Activity in Human Endothelial Cells -- Abstract -- Introduction -- Aim of this Study -- Material and Methods -- Results (Table 1) -- Conclusion -- Acknowledgments -- References -- The Proper Use of Angiotensin-Converting Enzyme Inhibitors in Patients with Chronic Kidney Disease -- Abstract -- Introduction -- Effects of ACE inhibitors on Renal and Glomerular Hemodynamics -- Effects of ACE Inhibitors on Proteinuria -- Increasing the Doses of ACE Inhibitors or the Addition of ARB? -- Excretion and Plasma Concentration of ACE Inhibitors in Patients with Chronic Renal Failure -- Upper Limit of Serum Creatinine to Add on ACE Inhibitor -- Long-Term Renoprotective Effects and Escape Phenomenon by Use of ACE Inhibitors -- Side Effects of ACE Inhibitors in Patients with Chronic Renal Failure -- Influence of Gene Polymorphisms on Renoprotective Effects of ACE Inhibitors -- Compliance of Taking ACE Inhibitors -- Additional Therapy with ACE Inhibitors.

Clinical Approach for Proper Use of ACE Inhibitors -- Summary -- Patients and Methods -- Acknowledgements -- References -- Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function -- Abstract -- Abbreviation: -- * Median follow-up -- Potential Mechanisms of ACEI Beneficial Activity in Patients with CAD -- Clinical Uses of ACEI in Cardiovascular Diseases -- Randomized Clinical Trials Examining the Use of ACEI in Patients with CAD and Preserved LV Systolic Function -- Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme (IMAGINE) Trial -- Meta Analysis of the Effects of ACEI in Patients with Normal LV Function and CAD -- Putting it Together -- References -- Dual Blockade of the Renin-Angiotensin System: Angiotensin Converting Enzyme Inhibition, Angiotensin Receptor Blockade and Renin Inhibition -- Abstract -- Introduction -- Differences in the Mechanisms of Action of RAS Blockers -- Rationale of Dual RAS Blockade -- Dual RAS Blockade and Blood Pressure -- Dual RAS Blockade and Target Organ Damage -- Dual RAS Blockade and Cardiovascular-Renal Outcome -- Safety of Long-Term Dual RAS Blockade -- Conclusion -- References -- Angiotensin-Converting Enzyme Inhibitors in Patients with Bilateral Atherosclerotic Renal Artery Stenosis -- Abstract -- Introduction -- Definition -- Pathophysiology -- Clinical Manifestations -- Diagnosis -- Therapeutic Approach -- Cardiovascular Risk Associated with Aras -- Angiotensin Inhibitors in Animal Studies of ARAS -- Angiotensin Inhibitors in Human Studies of ARAS -- Acute Renal Failure and ACE Inhibitors -- Heterogeneity of Patient Subtypes -- Future Perspectives -- Conclusion -- References -- Angiotensin Converting Enzyme Inhibitors in Renal Disease -- Introduction.

The Experimental Basis of Ace Inhibitors Nephroprotection -- Renin-Angiotensin System Actions Inside the Kidney -- Proposed Mechanisms for Renoprotection -- Clinical Use of Ace Inhibitors in Renal Disease -- Beyond Blood Pressure Control? -- Meta-Analyses on Renoprotective Effects of Ace Inhibitors -- Combination of Ace Inhibitors and ARBS in Renal Disease -- Ace Inhibitors or ARBS for Renal Disease?. -- Safe Use in Patients with Renal Failure -- References -- The Kallikrein- Kinin Pathways in Mediating the Hypotensive Action of Angiotensin Converting Enzyme (ACE) Inhibitors -- Abstract -- Introduction -- Kallikrein-Kinin System -- Kinin Receptors -- Kallikrein-Kinin and Renin Angiotensin Systems Interaction -- Kallikrein-Kinin System During Hypertension -- Antihypertensive Effects of Kininase II Inhibitors (ACEIs) -- Kinin Receptors Antagonists and Angiotensin Converting Enzyme (Kininase Ii) Inhibitors -- Summary -- References -- Angiotension Converting Enzyme Inhibitors: Improving Utilization and Adherence -- Abstract -- Introduction -- Magnitude of the Problem -- Barriers to Use -- Improving Adherence: Solutions -- Conclusion -- References -- Angiotensin Blockade in Pediatric Chronic Kidney Disease -- Abstract -- Introduction -- Renoprotection from Angiotensin Blockade -- Pediatric Studies on Angiotensin Blockade -- Effect On Proteinuria -- Effect on BP -- Progression of CKD -- Safety Considerations -- Conclusion -- References -- Index.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.